Heterogeneous Reduction in Paediatric RSV Hospitalisations Following Regional Nirsevimab Immunisation Strategies: A Multicentre Study

Study limitation reported by the research below: “The level of evidence is rated 3 (retrospective cohort); the study explicitly cannot establish causation or compare effectiveness between regional strategies.”